首页> 外国专利> Improvement of sexual arousal, sexual desire, orgasm, and / or pleasure following administration of intravaginal prasterone (dhea) in women who do not suffer from or independent of dyspareunia or other symptoms of vulvo-vaginal atrophy

Improvement of sexual arousal, sexual desire, orgasm, and / or pleasure following administration of intravaginal prasterone (dhea) in women who do not suffer from or independent of dyspareunia or other symptoms of vulvo-vaginal atrophy

机译：在没有遭受或独立于性交困难或外阴阴道萎缩的其他症状的女性中，服用阴道内甲亢（dhea）后，改善了性唤起，性欲，性高潮和/或愉悦

页面导航

摘要
著录项
相似文献

摘要

Abstract Improvement of sexual arousal, sexual desire, orgasm, and / or pleasure following administration of intravaginal prasterone (dhea) in women who do not suffer from or independent of dyspareunia or other symptoms of vulvovaginal atrophy is intravaginal dhea that is used for treating at least one condition selected from the group consisting of female hypoactive sexual desire disorder, female sexual arousal disorder, female orgasm disorder, and female sexual interest arousal disorder in a woman who either (1) is not suffering of symptoms of vulvovaginal atrophy and / or (2) is not suffering from moderate to severe dyspareunia.

机译：摘要对于未患有或独立于性交困难或外阴萎缩的其他症状的女性，经阴道内使用吡ster酮（dhea）后，改善性唤起，性欲，性高潮和/或愉悦是阴道内dhea，至少可用于治疗（b）（1）没有遭受外阴萎缩症状和/或（2）的女性的以下一种疾病：女性性欲减退，女性性唤起障碍，女性性高潮障碍和女性性唤起障碍。）没有中度至重度的性交困难。

著录项

公开/公告号BR112015001479A2

专利类型
公开/公告日2017-07-04

原文格式PDF
申请/专利权人 ENDORECHERCHE INC.;
展开▼

申请/专利号BR20151101479
发明设计人 FERNAND LABRIE;
展开▼

申请日2013-07-19
分类号A61K31/5685;A61P15;A61P15/02;A61P15/12;
国家 BR
入库时间 2022-08-21 13:40:16

相似文献

专利
外文文献